Daniel Oppenheim Upgraded (TMHC) to Buy and Increased Target to $17 on, Mar 8th, 2016
Daniel has made no other calls on TMHC in the last 4 months.
There are 2 other peers that have a rating on TMHC. Out of the 2 peers that are also analyzing TMHC, 1 agrees with Daniel's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Rehaut of "JP Morgan" Maintained at Hold with Decreased Target to $19 on, Wednesday, January 13th, 2016
This is the rating of the analyst that currently disagrees with Daniel
- Nishu Sood of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, February 9th, 2016
on: Mon, Feb 29th 2016
by: WOPRAI
Mark Shmulik Maintained (AMZN) at Buy with Decreased Target to $39 on, Feb 29th, 2016
on: Tue, Feb 09th 2016
by: WOPRAI
Nishu Sood Maintained (TMHC) at Strong Buy with Decreased Target to $20 on, Feb 9th, 2016
on: Fri, Jan 29th 2016
by: WOPRAI
Craig Siegenthaler Maintained (BX) at Buy with Increased Target to $31 on, Jan 29th, 2016
on: Fri, Jan 22nd 2016
by: WOPRAI
Susan Roth Katzke Maintained (BK) at Hold with Increased Target to $46 on, Jan 22nd, 2016
on: Mon, Mar 09th 2015
by: WOPRAI
Nishu Sood Maintained (TOL) at Strong Buy with Increased Target to $40 on, Mar 9th, 2015
on: Wed, Aug 14th 2013
by: WOPRAI
Jack Micenko Maintained (TMHC) at Buy with Decreased Target to $28 on, Aug 14th, 2013
on: Mon, Aug 12th 2013
by: WOPRAI
Peter Martin Initiated (TMHC) at Buy and Held Target at $30 on, Aug 12th, 2013
on: Tue, Mar 19th 2013
by: WOPRAI
Matthew O"Connor Maintained (C) at Strong Buy with Increased Target to $53 on, Mar 19th, 2013
on: Mon, Mar 11th 2013
by: WOPRAI
Brennan Hawken Upgraded (C) to Strong Buy on, Mar 11th, 2013
on: Mon, Mar 11th 2013
by: WOPRAI
Brennan Hawken Upgraded (C) to Strong Buy and Increased Target to $62 on, Mar 11th, 2013
on: Thu, Apr 19th 2012
by: WOPRAI
Alexander Blostein Maintained (BLK) at Hold with Decreased Target to $103 on, Apr 19th, 2012
on: Mon, Apr 09th 2012
by: WOPRAI
Daniel Fannon Maintained (BLK) at Hold with Increased Target to $98 on, Apr 9th, 2012